|
⚲
|
| Keyboard |
| Kaplan Brett
✚
|
|
|---|---|
| CIK # | 0001778763 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001778763] | |
| 4 | [0001778763] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kaplan Brett | |
| Climb Bio Inc | |
| Compass Therapeutics Inc | |
| Prevail Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Climb Bio Inc CLYM
Stock Option (Right to Buy) · derivative
|
2025-01-13 | Grant | 500,000 | $0.00 | |
|
Climb Bio Inc ELYM
Stock Option (Right to Buy) · derivative
|
2024-08-26 | Grant | 465,000 | $0.00 | |
|
Climb Bio Inc ELYM
Restricted Stock Units · derivative
|
2024-08-26 | Grant | 77,500 | $0.00 | |
|
Compass Therapeutics Inc CMPX
Stock Option (Right to Buy) · derivative
|
2022-02-18 | Grant | 30,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 95,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 347,004 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 64,565 | $0.00 | |
|
Compass Therapeutics Inc NONE
Stock Option (Right to Buy) · derivative
|
2020-09-10 | Grant | 60,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2020-02-19 | Grant | 95,000 | $0.00 |